據報小米(01810.HK)與InterDigital結束專利訴訟並達成全球許可協議
外媒報道,InterDigital(IDCC.US)和小米(01810.HK)達成一項為期多年的全球非獨家專利許可協議,解決小米使用InterDigital涉及各種移動技術的專利方面的法律糾紛。
該許可涵蓋InterDigital與蜂窩無線(包括 3G、4G 和 5G)、WiFi 和HEVC視頻技術相關的標準基本專利下的小米蜂窩移動設備。
兩家公司在中國和印度都有訴訟,涉及InterDigital的一些標準必要專利(SEPs)的技術使用和許可費率等方面。隨著新協議的簽訂,雙方都同意撤銷所有未決的法律訴訟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.